SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013591
Filing Date
2023-08-07
Accepted
2023-08-07 16:09:56
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20230630x10q.htm   iXBRL 10-Q 1620619
2 EX-10.1 ocul-20230630xex10d1.htm EX-10.1 63020
3 EX-10.2 ocul-20230630xex10d2.htm EX-10.2 82140
4 EX-31.1 ocul-20230630xex31d1.htm EX-31.1 12009
5 EX-31.2 ocul-20230630xex31d2.htm EX-31.2 8449
6 EX-32.1 ocul-20230630xex32d1.htm EX-32.1 4991
7 EX-32.2 ocul-20230630xex32d2.htm EX-32.2 4972
  Complete submission text file 0001558370-23-013591.txt   6289336

Data Files

Seq Description Document Type Size
8 EX-101.SCH ocul-20230630.xsd EX-101.SCH 43364
9 EX-101.CAL ocul-20230630_cal.xml EX-101.CAL 51079
10 EX-101.DEF ocul-20230630_def.xml EX-101.DEF 182848
11 EX-101.LAB ocul-20230630_lab.xml EX-101.LAB 326018
12 EX-101.PRE ocul-20230630_pre.xml EX-101.PRE 294509
66 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20230630x10q_htm.xml XML 936572
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 231147705
SIC: 2834 Pharmaceutical Preparations